Latest 10-K annual reports

Vocodia Holdings Corp's 2024 annual report reveals a significant revenue drop due to product suspension and ongoing legal battles, raising concerns about the company's financial stability.

Borealis Foods Inc. files Amendment No. 1 to its Form 10-K/A to include Part III information regarding directors, executive officers, compensation, security ownership, related party transactions, and principal accountant fees, along with updated certifications.

Shattuck Labs files an amendment to its 2024 Annual Report on Form 10-K/A to include information required by Items 10 through 14 of Part III, covering directors, executive compensation, security ownership, related transactions, and principal accountant fees.

Dun & Bradstreet filed an amendment to its 2024 annual report, updating information on directors, officers, and executive compensation.

Data Storage Corporation files an amendment to its 2024 Annual Report on Form 10-K to include information required by Part III regarding directors, executive officers, and corporate governance.

Lantern Pharma files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive officers, and corporate governance.

INVO Fertility, formerly NAYA Biosciences, will refocus on its fertility business and divest its NAYA Therapeutics subsidiary after failing to gain shareholder support for key transaction elements.

Conifer Holdings files an amendment to its 2024 annual report, providing updated information on directors, executive compensation, related party transactions, and corporate governance.

Accelerate Diagnostics files an amendment to its 2024 annual report to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, and principal accountant fees.

Global Star Acquisition Inc. reports its 10-K filing, highlighting challenges with Nasdaq listing compliance and ongoing efforts to complete its merger with K Enter Holdings Inc.

Creative Media & Community Trust Corporation files an amendment to its 2024 annual report on Form 10-K to provide information previously omitted regarding directors, executive officers, corporate governance, executive compensation, security ownership, related transactions, and accountant fees.

Global Interactive Technologies, Inc. (GITS) reports its 2024 10-K filing, highlighting a year of restructuring, leadership changes, and strategic shifts towards its FANING platform, while addressing going concern uncertainties and outlining future growth strategies.

IGM Biosciences files an amendment to its annual report to provide additional details on its board of directors, executive compensation, and corporate governance practices.

RingCentral files an amendment to its 2024 annual report to include information required in Part III, related to directors, executive officers, and executive compensation.

Talphera, Inc. files an amendment to its 2024 Annual Report on Form 10-K to include updated information on directors, executive officers, corporate governance, executive compensation, and related matters.

bioAffinity Technologies files an amendment to its annual report on Form 10-K to include information required by Part III regarding directors, executive officers, and corporate governance.

IAC Inc. files an amendment to its 2024 Annual Report to include previously omitted information regarding directors, executive officers, corporate governance, executive compensation, security ownership, related transactions, and principal accountant fees.

The OLB Group files an amendment to its 2024 annual report to include auditor consents and updated certifications from its CEO and CFO.

Inseego Corp. files an amendment to its annual report on Form 10-K to update information regarding directors, executive officers, and corporate governance.

Braemar Hotels & Resorts files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive officers, and corporate governance.

Organogenesis Holdings Inc. files an amendment to its 2024 annual report on Form 10-K to include Part III information regarding directors, executive officers, corporate governance, and executive compensation.

Enhabit, Inc. files an amendment to its annual report on Form 10-K to include information previously omitted from Part III regarding directors, executive officers, and corporate governance.

Nu Ride Inc. files an amendment to its annual report on Form 10-K to include information required by Part III, which was previously omitted.

Enstar Group Limited files an amendment to its 2024 Annual Report on Form 10-K/A to include previously omitted information regarding directors, executive compensation, corporate governance, and related matters.

Scilex Holding Company files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding executive compensation and corporate governance.

Wave Life Sciences Ltd. files an amendment to its 2024 annual report, primarily to include previously omitted information regarding executive compensation, corporate governance, and updated certifications.

Xenetic Biosciences files an amendment to its 2024 annual report to include information previously omitted regarding directors, executive officers, compensation, and related matters.

Brookdale Senior Living files an amendment to its annual report to include previously omitted information regarding directors, executive compensation, and corporate governance, while also detailing executive leadership changes.

Six Flags Entertainment Corporation files an amendment to its 2024 annual report to include information on directors, executive compensation, and corporate governance.

Ocean Biomedical has filed an amendment to its annual report on Form 10-K to include information previously omitted regarding directors, executive officers, corporate governance, executive compensation, security ownership, related transactions, director independence, and principal accountant fees.